UpToDate for nurse practitioners: what an NP actually pays for clinical references

Buying clinical references as a nurse practitioner is harder than it should be, and not because the tools are complicated. It is because half the market will not tell you what it charges until you are already inside it.

Here is what is actually published, read at source in September 2026, and what an NP should buy in what order.

How much does UpToDate cost for a nurse practitioner?

Wolters Kluwer publishes no individual subscription price for UpToDate. There is no public rate card for a single clinician, and the figures circulating in comparison articles are estimates rather than quoted prices. That is not an oversight on our part: it is how the product is sold.

The American Association of Nurse Practitioners lists "member-exclusive discounts on UpToDate, DynaMed Plus and VisualDx" among its benefits, and its clinical reference tools page repeats that members receive a discounted rate. Neither page prints a percentage. Both point you to a member rate page you need to be signed in to see. So even the discount is unpriced from the outside.

The practical consequence is that you cannot budget for UpToDate before joining something. If you see a specific dollar figure or a specific percentage quoted for AANP members on a third-party site, treat it as unverified, because the two organizations that would know both decline to publish it.

TRC does the opposite, and it is worth knowing why that matters

TRC Healthcare publishes its AANP rate in the open, on a public landing page, with the before and after figures printed next to each tier. Professional members take 33% off. Student members take 50% off. You can price the subscription today, without a membership, without a login, without talking to anyone.

That is a small thing that tells you something real about how a vendor sells. A published rate is a rate you can compare, put in a budget request, and hold the vendor to at renewal. An unpublished one is a negotiation you enter without information.

The list price ranges are not sloppiness. TRC publishes two slightly different figures for the APRN edition on its own properties: the product page and the AANP student page both say $143 Gold and $205 Platinum, while the AANP professional member page says $149 and $199. Both are TRC pages. We publish both rather than pick one, and the discounted figures above are the ones TRC prints directly.

TRC also states that these member rates apply to multi-year and renewal purchases, so they stack with the 10% discount on a two-year term and the 15% discount on a three-year term. An AANP member on a three-year Gold term is paying a long way below the sticker price.

Do nurse practitioners pay less than physicians for the same subscription?

For Prescriber Insights, yes, and the gap is bigger than most people expect. TRC sells the newsletter as three separately accredited editions and prices them differently. At Gold the APRN edition is $143 against $149 for physicians, which is trivial. At Diamond it is $389 against $599, a $210 difference for the same underlying publication.

What differs between the editions is the accreditation attached to the continuing education, not the drug therapy content. If you have ever wondered whether you were on the right product page, this is why it matters: ordering through the legacy Prescriber's Letter page gets you the APRN edition, which is cheaper but carries APRN accreditation. The full breakdown of every tier, term and credential is on our Prescriber's Letter cost guide.

Where Epocrates fits

Epocrates is the tool most NPs actually reach for on a phone, and the free tier is genuinely usable for basic drug lookups and pill identification. The paid tier, epocrates+, is priced at $179.99 a year, which we verified in the App Store in September 2026. Epocrates does not make that figure easy to find on the web, and the app itself lists no in-app purchase rate card through the public store API.

The honest assessment: Epocrates is a fast lookup tool, not an evidence reference and not a monthly briefing. It answers "what is the usual dose and does this interact" quickly. It does not answer "what does the current evidence say about managing this condition", which is the job UpToDate does. Paying for both is common and is not necessarily wasteful, but it is two budget lines and worth naming as such.

What should a nurse practitioner actually buy first?

Check institutional access before you buy anything. This is the single most common waste in the category. Hospital systems, university libraries and larger group practices frequently license UpToDate, and a surprising number of NPs pay personally for something their badge already unlocks. Ask the medical library or whoever administers clinical software, not your immediate manager, because the license usually sits in a different department from the one that answers questions about it.

If nothing is provided, buy the point of care lookup before the monthly briefing. A newsletter tells you what changed last month, which is valuable over a year. A lookup tool answers the question in front of you during the visit you are currently in. Only one of those changes what happens to the patient today, and if your budget stretches to one subscription it should be that one.

Then decide about continuing education separately. If you would buy CE anyway, a tier that bundles it is doing real work. If you would not, you are paying for a library you will not open. The Diamond tier at $389 bundles TRC's full continuing education library and a NatMed Pro subscription that sells standalone at $182, which makes it good value for an APRN specifically. The same bundle at the physician price of $599 does not clear that bar.

The expense side, which nobody plans for

Most NPs buying these subscriptions personally are doing it against an employer CME or professional development allowance, and that means keeping the receipts in a form someone in finance will accept months later. Multi-year terms make this worse, because a three-year charge lands once and then has to be justified against an annual allowance. It helps to have somewhere to pull receipts and categorize them without hunting through email when the reimbursement window opens, rather than reconstructing a year of subscription charges from memory.

Diary the renewal date too. TRC charges multi-year terms once, up front, and the renewal arrives long after you have forgotten what you agreed to.

What none of these tools do

Every product on this page is a reference. You go to it with a question, and it gives you an answer. That model works well when you already know what to ask.

It works less well for the problem that actually generates most prescribing errors, which is the interaction or contraindication nobody thought to look up. A patient on nine medications does not arrive with a question attached. Screening that list against interactions, contraindications and renal dosing thresholds is a different job, done by a tool that reads the whole list rather than waiting to be queried, which is what our drug interaction checker is built for. If you are still mapping out what the paid options cost across the whole category, the published prices are collected on our drug reference app comparison.

Reference tools and screening tools are complementary, not competing, and the budget conversation goes better when you say that out loud rather than trying to make one product do both jobs.